Korean Consensus Criteria for the Severity Classification of Alopecia Areata

January 2024 in “ Annals of Dermatology ”

Yong Hyun Jang, S. Lee, Do Young Park, Young Lee, Do Young ‍Kim, Hyunsun Park, Hyun‐Tae Shin, Jung Eun Kim, Kihyuk Shin, Ji Hae Lee, Jee Woong Choi, Byung Cheol Park, Beom Joon Kim, Soo Hong Seo, Chong Hyun Won, Jin Park, Min Sung Kim, Sang Seok Kim, Bark‐Lynn Lew, Chang‐Hun Huh, Ohsang Kwon, Yang Won Lee, Moon‐Bum Kim

alopecia areata severity classification diagnosing treatment monitoring patient outcomes clinical settings

TLDR The criteria help doctors diagnose and treat alopecia areata more effectively.

The Korean Consensus Criteria for the Severity Classification of Alopecia Areata (AA) aim to assist clinicians in accurately diagnosing the condition, determining the appropriate treatment, and monitoring its progression. By establishing standardized criteria, the guidelines facilitate a more uniform approach to managing AA, which can lead to improved patient outcomes. The criteria are designed to be practical and applicable in clinical settings, ensuring that patients receive consistent and effective care.

View this study on anndermatol.org →

Discuss this study in the Community →

Research cited in this study

21 / 21 results

research Guidelines for the Management of Patients with Alopecia Areata in Korea: Part I Topical and Device-Based Treatment

6 citations , January 2023 in “Annals of Dermatology”

The guidelines offer updated treatment recommendations for alopecia areata in Korea using topical and device-based methods.

research Anxiety, Depression, and Quality of Life in Children and Adults With Alopecia Areata: A Systematic Review and Meta-Analysis

4 citations , November 2022 in “Frontiers in Medicine”

People with alopecia areata are more likely to have anxiety and depression and a lower quality of life.

research The Efficacy and Safety of JAK Inhibitors for Alopecia Areata: A Systematic Review and Meta-Analysis of Prospective Studies

37 citations , August 2022 in “Frontiers in pharmacology”

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

research Two Phase 3 Trials of Baricitinib for Alopecia Areata

148 citations , March 2022 in “The New England Journal of Medicine”

Baricitinib was effective in treating alopecia areata in two major trials.

research A Phase 2a Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of the Oral Janus Kinase Inhibitors Ritlecitinib and Brepocitinib in Alopecia Areata: 24-Week Results

138 citations , March 2021 in “Journal of the American Academy of Dermatology”

Ritlecitinib and brepocitinib effectively regrow hair in alopecia areata patients.

research Development and Validation of the Brigham Eyelash Tool for Alopecia: A Measure of Eyelash Alopecia Areata

6 citations , March 2021 in “Journal of the American Academy of Dermatology”

The Brigham Eyelash Tool for Alopecia (BELA) is a reliable way to measure eyelash loss in alopecia areata patients.

research Brigham Eyebrow Tool for Alopecia: A Reliable Assessment of Eyebrow Alopecia Areata

4 citations , November 2020 in “Journal of Investigative Dermatology Symposium Proceedings”

The Brigham Eyebrow Tool for Alopecia is a simple and reliable way to measure eyebrow hair loss.

research Consensus on the Treatment of Alopecia Areata – Brazilian Society of Dermatology

23 citations , October 2020 in “Anais brasileiros de dermatologia/Anais Brasileiros de Dermatologia”

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

Development of Clinician-Reported Outcome and Patient-Reported Outcome Measures for Eyebrow, Eyelash, and Nail Assessment in Alopecia Areata

research Development of Clinician-Reported Outcome and Patient-Reported Outcome Measures for Eyebrow, Eyelash, and Nail Assessment in Alopecia Areata

56 citations , August 2020 in “American Journal of Clinical Dermatology”

New tools help assess eyebrow, eyelash, and nail changes in Alopecia Areata, improving understanding of patient experiences.

research Cyclosporine With and Without Systemic Corticosteroids in Treatment of Alopecia Areata: A Systematic Review

13 citations , April 2020 in “Dermatology and therapy”

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

research The Alopecia Areata Investigator Global Assessment Scale: A Measure for Evaluating Clinically Meaningful Success in Clinical Trials

86 citations , January 2020 in “British Journal of Dermatology”

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

research Italian Guidelines in Diagnosis and Treatment of Alopecia Areata

37 citations , December 2019 in “Giornale italiano di dermatologia e venereologia”

The Italian guidelines offer advice for diagnosing and treating alopecia areata based on expert opinion and limited clinical trial evidence.

research Cyclosporine for Moderate-to-Severe Alopecia Areata: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial of Efficacy and Safety

44 citations , April 2019 in “Journal of the American Academy of Dermatology”

Cyclosporine showed some improvement in alopecia areata but results were not statistically significant.

research Treatment of Alopecia Areata: An Australian Expert Consensus Statement

95 citations , November 2018 in “Australasian journal of dermatology”

Alopecia areata treatment varies, with no optimal method established yet.

research Alopecia Areata: Treatment Options and Efficacy

182 citations , December 2017 in “Journal of the American Academy of Dermatology”

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Alopecia Areata: Overview and Insights from January 2018